|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eloubeidi MA, Desmond R, Arguedas MR, Reed
CE and Wilcox CM: Prognostic factors for the survival of patients
with esophageal carcinoma in the US: The importance of tumor length
and lymph node status. Cancer. 95:1434–1443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wilson M, Rosato EL, Chojnacki KA,
Chervoneva I, Kairys JC, Cohn HE, Rosato FE Sr and Berger AC:
Prognostic significance of lymph node metastases and ratio in
esophageal cancer. J Surg Res. 146:11–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veikkola T and Alitalo K: VEGFs, receptors
and angiogenesis. Semin Cancer Biol. 9:211–220. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Achen MG and Stacker SA: Molecular control
of lymphatic metastasis. Ann NY Acad Sci. 1131:225–234. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stacker SA, Caesar C, Baldwin ME, Thornton
GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H and Achen
MG: VEGF-D promotes the metastatic spread of tumor cells via the
lymphatics. Nat Med. 7:186–191. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shida A, Fujioka S, Ishibashi Y, Kobayashi
K, Nimura H, Mitsumori N, Suzuki Y, Kawakami M, Urashima M and
Yanaga K: Prognostic significance of vascular endothelial growth
factor D in gastric carcinoma. World J Surg. 29:1600–1607. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kozlowski M, Naumnik W, Niklinski J,
Milewski R, Dziegielewski P and Laudanski J: Vascular endothelial
growth factor C and D exprossion correlates with lymph node
metastasis and poor prognosis in patients with resected esophageal
cancer. Neoplasma. 58:311–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Breiteneder-Geleff S, Soleiman A, Kowalski
H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler
E, Alitalo K, et al: Angiosarcomas express mixed endothelial
phenotypes of blood and lymphatic capillaries: Podoplanin as a
specific marker for lymphatic endothelium. Am J Pathol.
154:385–394. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kozłowski M, Naumnik W, Nikliński J,
Milewski R, Lapuć G and Laudański J: Lymphatic vessel invasion
detected by the endothelial lymphatic marker D2-40 (podoplanin) is
predictive of regional lymph node status and an independent
prognostic factor in patients with resected esophageal cancer.
Folia Histochem Cytobiol. 49:90–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kozłowski M, Niklińska W, Naumnik W,
Laudański W, Milewski R and Nikliński J: Intratumoral lymphatic
vessel density and intratumoral and peritumoral lymphatic vessel
invasion as predictive factors of lymph node metastasis and
prognostic factors in esophageal cancer. Kardiochir Torakochir Pol.
10:120–129. 2013.
|
|
12
|
Wicki A, Lehembre F, Wick N, Hantusch B,
Kerjaschki D and Christofor G: Tumor invasion in the absence of
epithelial-mesenchymal transition: Podoplanin-mediated remodeling
of the actin cytoskeleton. Cancer Cell. 9:261–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: Esophagus and esophagogastric junction.
AJCC cancer staging manual. Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: (7th). (New York, NY). Springer. 103–107.
2010.
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sporn MB: The war on cancer. Lancet.
347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hirakawa S, Brown LF, Kodama S, Paavonen
K, Alitalo K and Detmar M: VEGF-C-induced lymphangiogenesis in
sentinel lymph nodes promotes tumor metastasis to distant sites.
Blood. 109:1010–1017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kozłowski M, Laudański W, Mroczko B,
Szmitkowski M, Milewski R and Łapuć G: Serum tissue inhibitor of
metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor
A (VEGF-A) are associated with prognosis in esophageal cancer
patients. Adv Med Sci. 58:227–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakayama Y, Matsumoto K, Nagato M, Inoue
Y, Katsuki T, Minagawa N, Shibao K, Tsurudome Y, Hirata K, Higure
A, et al: Significance of lymphangiogenesis as assessed by
immunohistochemistry for podoplanin in patients with esophageal
carcinoma. Anticancer Res. 27:619–625. 2007.PubMed/NCBI
|
|
19
|
Kimura H, Kato H, Tanaka N, Inose T,
Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, et
al: Preoperative serum vascular endothelial growth factor-C
(VEGF-C) levels predict recurrence in patients with esophageal
cancer. Anticancer Res. 28:165–169. 2008.PubMed/NCBI
|
|
20
|
Okazawa T, Yoshida T, Shirai Y, Shiraishi
R, Harada T, Sakaida I, Abe T and Oka M: Expression of vascular
endothelial growth factor C is a prognostic indicator in esophageal
cancer. Hepatogastroenterology. 55:1503–1508. 2008.PubMed/NCBI
|
|
21
|
Tanaka T, Ishiguro H, Kuwabara Y, Kimura
M, Mitsui A, Katada T, Shiozaki M, Naganawa Y, Fujii Y and Takeyama
H: Vascular endothelial growth factor C (VEGF-C) in esophageal
cancer correlates with lymph node metastasis and poor patient
prognosis. J Exp Clin Cancer Res. 29:832010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tong L, Yuan S, Feng F and Zhang H: Role
of podoplanin expression in esophageal squamous cell carcinoma: A
retrospective study. Dis Esophagus. 25:72–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahadiani N, Ikeda JI, Makino T, Tian T,
Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K and Morii E: Tumorigenic
role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg
Oncol. 17:1311–1323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tzao C, Lee SC, Tung HJ, Hsu HS, Hsu WH,
Sun GH, Yu CP, Jin JS and Cheng YL: Expression of hypoxia-inducible
factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D
as outcome predictors in resected esophageal squamous cell
carcinoma. Dis Markers. 25:141–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitadai Y, Amioka T, Haruma K, Tanaka S,
Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K:
Clinicopathological significance of vascular endothelial growth
factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J
Cancer. 93:662–666. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimura Y, Watanabe M, Ohaga T, Saeki H,
Kakeji Y, Baba H and Maehera Y: Vascular endothelial growth factor
C expression correlates with lymphatic involvement and poor
prognosis in patients with esophageal squamous cell carcinoma.
Oncol Rep. 10:1747–1751. 2003.PubMed/NCBI
|
